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Abstract 
The cytosolic, alkaline RNase in rat vaginal epithelial cells (VBC) from normal, immature rats was found to be present largely in the free, active 
form unlike in many other mammalian tissues where it is known to be present in a latent form as a complex with RNase inhibitor (RNasin). Estradiol 
(Ed administration induced expression of RNasin activity in the VEC from such animals and caused virtually total inhibition of cytosolic RNase 
activity in these cells by 12 h after the hormone injection. These changes may have metabolic implications in relation to other biochemical events 
stimulated by estradiol in rat VEC. 
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1. Introduction 
The cytosolic compartment of mammalian cells con- 
tains a major alkaline or neutral RNase which is believed 
to be present in latent form as a complex with a cytosolic 
protein - the RNase inhibitor (RNasin) and the RNase- 
RNasin system is implicated in the regulation of cy- 
tosolic RNase activity. The level of RNasin, for example, 
may vary with the metabolic status of the cells or tissue 
and thus influence RNase activity [l]. Estradiol (EJ- 
induced modulation of the RNase-RNasin system has 
been reported earlier [2-51 in uterus which is a major 
target tissue for E, action. The hormone has also been 
shown to regulate the turnover of many mRNAs [q. 
These two effects of E, may imply a regulatory relation- 
ship, i.e. E, may modulate the RNase-RNasin ratio or 
the complex formation, influence cellular RNase activity 
which in turn may effect the degradation of cytoplasmic 
mRNA(s). Earlier studies with the uterus have revealed 
that in ovariectomised animals, Ez caused some reduc- 
tion (l&50%) in the levels of uterine cytosolic RNase 
activity [2,3]. In immature rat uterus on the other hand, 
the hormone caused an increase in the levels of both 
RNase and RNasin [4,5] and the net RNase activity was 
higher than that in the control [5]. Moreover, the in- 
crease in the levels of both the RNase and RNasin is not 
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consistent with the expected reciprocal changes in the 
levels of these two proteins if RNase activity is to be 
modulated. Vaginal epithelial cells (VEC) are also a tar- 
get for E, action and undergo E,-induced growth and 
differentiation; VEC differ from uterine epithelial cells 
particularly in the process of terminal differentiation. 
Rat VEC have, therefore, been used as a system to study 
E,-induced cellular and biochemical changes [7-91. In 
this report, we present data on the cytosolic RNase activ- 
ity in VEC from rats administered with EZ. The hormone 
treatment was found to cause a profound decrease in the 
net cytosolic RNase activity (as a result of formation of 
the RNase-RNasin complex) in these cells in contrast to 
the observations with uterine cells. 
2. Materials and methods 
2.1. E, treatment and preparation of rat VEC 
Immature (30~day-old) female Wistar rats were injected intraperi- 
toneally with E, in 50% ethanol (10 pg/lOO g b.wt.) and were killed at 
specific time intervals after the hormone injection. Controls received a 
same volume of vehicle. Vagina from the control and I$ treated animals 
were dissected out and collected in cold phosphate-buffered saline 
(PBS). The vagina were slit longitudinally and the epithelial cells were 
scraped gently with the help of a clean glass slide [IO]. 
2.2. Preparation of cytosolic fraction 
The VEC were washed three times with cold PBS and resuspended 
and son&ted in a buffer containing 25 mM Tris, 100 mM NaCI, 10 
mM DlT, 1 mM EDTA and 0.25 M sucrose. Sonication was optimized 
for the minimal damage of nuclei (unpublished results). The souicate 
was centrifuged at 100,000 x g for 1 h at 4°C. The supematant (SIOO 
fraction or the cytosolic fraction) was collected and stored frozen. 
Protein estimation was done by Lowry’s method [l l] after TCA precip- 
itation of the SlOO fraction. 
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2.3. Isolation of RNA 
Total RNA from logarithmically growing E. coli (used as substrate 
in RNase assays) was isolated by phenol extraction as described by us 
earlier [12]. The quality of the RNA was assessed by agarose gel electro- 
phoresis. 
2.4. Rhkse assays 
RNase assays were done using agarose gel electrophoresis e sentially 
as described in [12]. In a typical assay, 1 pug of total RNA (rat spleen 
or E. colt] was incubated with various concentrations of SlOO fractions 
from rat VEC (2-200 ng of total protein) in 10 ~1 buffer containing 20 
mM Tris. nH 7.8. 100 mM NaCl. 10 mM DTT. for 30 min at 37°C 
(DTT was omitted when assays were done in the presence ofp-chlorom- 
ercuric benzoate (pCMB); see Fig. 3). At the end of the incubation, 
samples were electrophoresed in a 1% agarose gel in 0.09 M Tris- 
Borate, EDTA buffer (PH 8). RNA in the gel was visualized by ethid- 
ium bromide staining. Degradation was assessed by disappearance of 
the rRNA bands and degradation comparisons were made in terms of 
the minimum amount of protein required for complete and clear disap- 
pearance of the rRNA bands and productions of degradation fragments 
of the size of 4 S or smaller. 
3. Results and discussion 
For the study of RNase activity in VEC, we routinely 
used an RNase assay procedure which is based on aga- 
rose gel electrophoretic separation of the reaction prod- 
ucts from the substrate wherein the extent of degradation 
is correlated with visually assessed, disappearance of 
rRNA bands and formation of products with greater 
electrophoretic mobility. The procedure is adequate for 
semi-quantitative comparison of relative RNase levels 
and in this respect, it is more sensitive than other proce- 
dures for assaying RNase activity such as the spectro- 
photometric method or the one based on cCMP hydrol- 
ysis [13,14]. These methods detect the activity of ng 
quantities of bovine pancreatic RNase A but the method 
as described here can be conveniently used with as low 
as pg levels of RNase A (80 pg or 0.25 units as in assays 
reported in [12]). Greater detection sensitivity of this 
procedure and the use of electrophoretic analysis of the 
reaction mixture would allow detection of RNase activ- 
ity even when acid soluble degradation products are not 
produced (as in assays for angiogenin [15] and as would 
be expected with very low levels of free cytosolic RNase 
activity). 
When the S 100 fraction from rat VEC was assayed for 
RNase activity at different pHs (Fig. lA), the activity 
was observed mostly in the alkaline pH range with a pH 
maximum around 7.5 and 8. No significant activity could 
be detected at acidic pH between 4.5 and 6.0. Also, the 
RNase activity detected in our assays could be com- 
pletely inhibited in the presence of RNasin (Fig. 1B). 
Absence of detectable activity at acidic pH and almost 
total inhibitability of the activity observed in our assays 
by added RNasin rule out the possibility of any contam- 
ination by lysosomal RNases in our SlOO preparations; 
lysosomal fraction of mammalian cells contains acidic 
RNase insensitive or partially sensitive to RNase inhibi- 
tor [16]. Moreover, on electron microscopic examina- 
tion, the number of lysosomes in rat VEC were found to 
be very low as compared to other cell types (unpublished 
results). Thus, we believe that all the activity detected in 
our assays represents inhibitor-responsive, cytosolic al- 
kaline RNase of the rat VEC. In Fig. 2, a comparison 
of cytosolic RNase activity from immature rat VEC at 
specific time periods after estradiol injection is shown. 
The RNase activity was compared in terms of the mini- 
mum amount of cytosolic protein required to cause dis- 
appearance of the substrate rRNA bands on electropho- 
resis. A wide range of SlOO protein amounts were tried 
in pilot experiments and on the basis of those results, the 
range was chosen for the experiment shown in the Fig. 
2. RNase activity in the VEC from the untreated controls 
could be detected with 4-10 ng of cytosolic protein. The 
activity levels were found to be somewhat reduced in cells 
from 3-h E,-treated animals and 10-20 ng of SlOO pro- 
tein were required to observe RNase activity. With 6-h 
E,-treated samples, RNase activity was apparent with 
60-80 ng of SlOO protein. Much higher protein amounts 
were to be used when 12-h and 24-h E,-treated samples 
were studied. With 12-h E,-treated samples, no detecta- 
ble RNase activity was observed even with 200 ng (400 
ng in another experiment) of protein whereas with 24-h 
hormone-treated samples RNase activity could be de- 
tected above 80 ng of SlOO protein. From this and other 
experiments, we conclude that the cytosolic RNase activ- 
ity levels drop progressively after E, injection such that 
by 12 h it reaches the lowest level and tends to rise 
thereafter. 
Cellular alkaline or neutral RNase exists in cytosol 
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Fig. 1. Characteristics of the total ribonuclease activity of the SlOO 
fraction of the VEC. (A). The effect of pH on nuclease activity. 10 ng 
of SlOO protein of the VEC was incubated with 1 pg of RNA at 37°C 
for 30 min in a buffer of different pH. For pH 4.5 and 5.0, 20 mM 
sodium acetate buffer, for pH 6.7,20 mM phosphate buffer and for pH 
7.5 to 9.0, 20 mM Tris-HCl buffer was used. The SlOO fraction was 
diluted at least loo-fold in the respective buffer for the assay. After the 
reaction, the RNA was run in a 1% agarose gel and stained with EtBr. 
The nuclease activity was maximum at pH 7.58. (B) Effect of placental 
RNase inhibitor on the nuclease activity. 1 pg of total RNA was incu- 
bated as such (lane C) or with 10 ng of SlOO protein of the VEC in the 
absence (-Inh.) or presence (+Inh.) of increasing amounts (units) of 
human placental RNasin for 30 min at 37°C. At the end of incubation, 
RNA was analysed as in (A). The nuclease activity was sensitive to 
added RNase inhibitor. 
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Fig. 2. Levels of alkaline RNase in SlOO fraction of VEC from control and E, injected rats. SlOO fractions were prepared from VEC from control 
and E2 injected rats as described in section 2 and assayed for RNase activity as follows. 1 pg of total RNA was incubated with different amounts 
of SlOO fraction protein (2-200 ng) for 30 min at 37°C. RNA was analysed as in Fig. 1. In & treated animals, cytosolic alkaline RNase activity of 
the VEC reduced several fold by 12 h after hormone injection. 
largely in a latent form as a complex with RNasin. The 
main experimental evidence in support of this is that no 
RNase activity could be detected in the mammalian cy- 
tosolic fraction unless the inhibitor is inactivated by 
agents like pCMB [l]. With the use of the assay proce- 
dure described here even with 10 ,ug of the cytosolic 
protein fraction from rat liver, no detectable RNase ac- 
tivity could be observed when the assay did not include 
pCMB (data not shown). The situation with the rat VEC 
appears to be different in that the enzyme activity could 
be detected even in the absence of pCMB (Fig. 2) sug- 
gesting the presence of significant amounts of free, active 
RNase in these cells. Furthermore, Fig. 3 shows the lev- 
els of the free and total cytosolic RNase activity of VEC 
from E,-treated and untreated rats when the assays were 
done in the absence or presence of 0.2 mM pCMB. The 
results indicated: (i) the RNase activity level detected in 
the SlOO fraction of VEC from the untreated control was 
similar in the assays done in presence or absence of 
pCMB (left sections) suggesting that virtually all the 
RNase in the control rat VEC exists in the free, active 
form and not as the latent, RNase-RNasin complex; (ii) 
the RNase activity in the S 100 fraction of the VEC from 
E,-treated animals could be released by pCMB treatment 
(right sections) and no significant difference was ob- 
served between the total RNase activity (lower sections; 
+ pCMB assays) of E,-treated and untreated samples. 
Therefore, reduced levels of RNase activity in 12-h Ez- 
treated samples (Figs. 2 and 3; -pCMB assays) appears 
not to be due to reduction in the amount of the RNase 
protein but due to induction of latency on account of 
complexing of the enzyme with RNasin; and (iii) the total 
activity level, i.e. the activity released by pCMB treat- 
ment (+pCMB assay), in E,-treated samples was equiva- 
lent to the activity level in the control VEC (in which 
almost all the RNase is present in free active form; see 
above). Therefore, on E, treatment (12 h), all the RNase 
in the VEC seemed to be complexed and inactivated by 
the inhibitor. Complex formation could occur either on 
activation of the pre-existing cytosolic inhibitor or as a 
result of induction of its expression by E,. We are pres- 
ently working on these two possibilities. The possibility 
of any property of the enzyme being responsible for it’s 
inhibitor-insensitivity in normal VEC is unlikely because 
the enzyme from the control tissue samples was poten- 
tially sensitive to added RNasin (Fig. 1). 
The exact role of the cytosolic RNase-RNasin system 
in mammalian tissue is not yet clear. There are some 
earlier reports about changes in the cytosolic RNase and 
inhibitor activity levels which may have metabolic impli- 
cations [ 1,171. The effect of E, on cytosolic, RNase levels 
in rat uterine tissue has also been reported earlier [2-51. 
E, treatment was found to result in concomitant increase 
in the levels of both RNase and the inhibitor in this tissue 
by 2-4 days after the hormone injection and the net 
RNase activity was higher than that in the control [5]. In 
view of its putative role in the regulation of RNase activ- 
ity, increase in the inhibitor levels is expected to correlate 
with decrease in cellular RNase activity [l], however the 
above observation with rat uterine tissue from immature 
animals was found to be inconsistent with this expecta- 
tion. These observations could not be accounted for by 
impurities in the cytosolic fractions used. It is unlikely 
that under the experimental conditions used by these 
researches, lysosomal RNase activity (RNase which is 
active at acidic pH and is partially sensitive to the inhib- 
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Fig. 3. Comparison of free (@MB) and total (+pCMB) RNase activity of VBC from control and E2 treated rats. RNase assays were done as in 
Fig. 2 but in the presence or absence of 0.2 mM pCMB (which inactivates the RNase inhibitor and releases RNase from the RNase - inhibitor 
complex). The amount of SlOO nrotein used for the assay was as indicated. There was virtually no latent RNase in control VEC whereas it was present _ 
in 12-h E,-treated samples. 
itor) could contaminate and be detected in the cytosolic 
fraction (‘high-speed supernate’). However, these au- 
thors could not rule out the possibility that their observa- 
tion could be attributed to the heterogeneity of the cell 
types in the rat uterus. In this investigation, early effects 
(O-24 h) of Ez administration were not studied. There- 
fore, our present results with rat VEC are difficult to 
compare with the above study using uterine tissue from 
immature rats. However, in an independent study, 
RNase levels in the uterine tissue from ovariectomised 
animals were studied [2,3] and were found to be low at 
6 h after the hormone treatment as compared with the 
control. Although the latter study is consistent with our 
observation with rat VEC, the decrease in the RNase 
activity level in rat VEC at 12 h after E2 injection ob- 
served by us, is more distinct (Fig. 2) when compared 
with the uterine tissue (18-50% decrease). Thus, our ob- 
servations with rat VEC indicate very strong modulation 
in the levels of the cytosolic RNase activity and this 
appears to be due to changes in the RNase-RNasin sys- 
tem triggered by an external signal like EZ. The findings 
may be useful not only to further study the mechanism 
of this process but also to explore the metabolic role of 
the RNase-RNasin system. 
Ez is also known to regulate the expression of several 
genes [18-201. In rat VEC, our earlier studies [8,9] have 
shown that the hormone stimulated several biochemical 
processes related to growth and differentiation. Other 
experiments (unpublished) in our lab have indicated that 
E,-treatment stimulated DNA synthesis in these cells and 
synthesis of a major proliferation-specific protein keratin 
and accumulation of its mRNA. Coincidently, E,-in- 
duced changes in the activity of cytosolic RNase and 
RNasin happen in parallel with both these biochemical 
events. A more extensive and independent study is re- 
quired to investigate whether all these changes have any 
metabolic relationship and rat VEC would be a very 
useful system for this purpose. 
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